Pennsylvania Removes Prior Authorization for Opioid Treatment
The
In addition to removing this unnecessary restriction on treatment, insurers have also committed to including a comprehensive range of medications to treat substance use disorders on the lowest cost-sharing tier of a health plan's pharmacy benefit as part of this agreement.
"We have long advocated for the removal of prior authorization and other barriers to increase access to medication-assisted treatment (MAT) for substance use disorders," said AMA President-elect
"We commend the governor for his leadership in bringing together all major stakeholders in reaching this agreement," said
Prior authorization--sometimes called precertification or prior approval--is a health plan process by which patients, physicians or other health care providers must obtain advance approval from a health plan to qualify for payment before a specific service is delivered to the patient. Applying prior authorization to patients with substance use disorders can have deadly consequences if patients are forced to delay care or have that care denied.
MAT is the evidence-based standard for treating people with opioid use disorder to help sustain recovery and save lives. In the past year, nearly 15,000 physicians have become certified to provide MAT--a 42 percent increase nationwide.
Liberty Appoints Markus Hefel to Senior Swiss Role
American Land Title Association Elects Cynthia Durham Blair NTP as President
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News